You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 64 Issue 2

August 2007

Volume 64, Issue 2

Pages 119–248

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
  2. Commentary

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
  3. Pharmacokinetics & pharmacodynamics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
    2. You have free access to this content
      Flavonoids inhibit the platelet TxA2 signalling pathway and antagonize TxA2 receptors (TP) in platelets and smooth muscle cells (pages 133–144)

      José A. Guerrero, Leyre Navarro-Nuñez, María L. Lozano, Constantino Martínez, Vicente Vicente, Jonathan M. Gibbins and 1 José Rivera

      Version of Record online: 10 APR 2007 | DOI: 10.1111/j.1365-2125.2007.02881.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    3. You have free access to this content
      Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight (pages 145–150)

      Tommaso Gori, Giuseppe Di Stolfo, Silvia Sicuro, Saverio Dragoni, Monica Lisi, Sandro Forconi and John D. Parker

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02864.x

      • image
      • image
      • image
  4. Pharmacokinetics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
      Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients (pages 151–164)

      Christa E. Nath, Peter J. Shaw, Kay Montgomery and John W. Earl

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02862.x

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites (pages 165–173)

      Miia Turpeinen, Niina Koivuviita, Ari Tolonen, Petri Reponen, Stefan Lundgren, Jouko Miettunen, Kaj Metsärinne, Anders Rane, Olavi Pelkonen and Kari Laine

      Version of Record online: 1 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02866.x

      • image
      • image
    3. You have free access to this content
  5. Pharmacogenetics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have full text access to this OnlineOpen article
      Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects (pages 185–191)

      Ji H. Choi, Yoon J. Lee, Seong B. Jang, Jong-Eun Lee, Kyung H. Kim and Kyungsoo Park

      Version of Record online: 28 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02874.x

      • image
  6. Drug safety

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Carisoprodol use and abuse in Norway. A pharmacoepidemiological study (pages 210–218)

      Jørgen G. Bramness, Kari Furu, Anders Engeland and Svetlana Skurtveit

      Version of Record online: 12 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02847.x

      • image
      • image
  7. Therapeutics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
      Exposure-toxicity relationships for tipifarnib in cancer patients (pages 219–232)

      Juan Jose Perez-Ruixo, Wei Chen, Steven Zhang, Siobhan Hayes and Andrew Chow

      Version of Record online: 22 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02883.x

      • image
      • image
      • image
      • image
  8. Short reports

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
      Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course (pages 233–236)

      G. Durrieu, C. Hurault, V. Bongard, C. Damase-Michel and J. L. Montastruc

      Version of Record online: 22 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02882.x

      • image
    2. You have free access to this content
      Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity (pages 237–240)

      Nicolas Magné, Marie-Christine Etienne-Grimaldi, Laurent Cals, Nicole Renée, Jean-Louis Formento, Mireille Francoual and Gérard Milano

      Version of Record online: 1 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02869.x

      • image
    3. You have free access to this content
      Age dependent systemic exposure to inhaled salbutamol (pages 241–244)

      Klaus Bønnelykke, Jakob Jessing Jespersen and Hans Bisgaard

      Version of Record online: 1 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02868.x

      • image
      • image
  9. Letters to the editors

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content
      Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients (page 245)

      Prasanna K. Subbanna, C. G. Prasanna and Bhagwat K. Gunale

      Version of Record online: 10 APR 2007 | DOI: 10.1111/j.1365-2125.2007.02891.x

    2. You have free access to this content
      Safety of amlodipine use in patients with acute intermittent porphyria (pages 246–247)

      Hakan Cinemre, Ugur Korkmaz, Aytekin Alcelik, Elif Onder and Adem Gungor

      Version of Record online: 18 APR 2007 | DOI: 10.1111/j.1365-2125.2007.02906.x

  10. Book review

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Pharmacokinetics & pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Drug safety
    8. Therapeutics
    9. Short reports
    10. Letters to the editors
    11. Book review
    1. You have free access to this content

SEARCH

SEARCH BY CITATION